Sanofi India Limited (BOM:500674)
3,139.90
-5.05 (-0.16%)
At close: Sep 25, 2026
Sanofi India Market Cap
Sanofi India has a market cap or net worth of 72.31 billion as of September 25, 2026. Its market cap has decreased by -37.08% in one year.
Market Cap
72.31B
Enterprise Value
68.77B
Revenue
18.05B
Ranking
n/a
PE Ratio
22.33
Stock Price
3,139.90
ChartMarket Cap Chart
Since March 19, 2001, Sanofi India's market cap has increased from 11.29B to 72.31B, an increase of 540.80%. That is a compound annual growth rate of 7.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 72.31B | -23.26% |
| Dec 31, 2025 | 94.23B | -33.15% |
| Dec 31, 2024 | 140.97B | -24.12% |
| Dec 29, 2023 | 185.79B | 37.91% |
| Dec 30, 2022 | 134.72B | -25.89% |
| Dec 31, 2021 | 181.78B | -5.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 170.13B |
| AstraZeneca Pharma India | 162.95B |
| Viyash Scientific | 106.69B |
| Procter & Gamble Health | 89.87B |
| Bliss GVS Pharma | 75.38B |
| Morepen Laboratories | 66.00B |
| FDC Limited | 55.53B |
| Novartis India | 48.43B |